Medical Blog About Treatment Abroad

With more than 1.9 million new cases and 0.9 million deaths in 2020, rectal cancer (RC) was the third most common cancer and the second most common cause of cancer mortality worldwide. Geographical disparities were reported in incidence and mortality rates, time trends, and the future burden of RC across different countries and...

Dendritic cell therapy for ulcerative colitis is an advanced approach focused on the individual characteristics of the patient’s body. This method is an innovative solution in the world of medicine and opens up new opportunities for those who are looking for effective ways to combat a chronic disease. Unlike standard treatments, dendritic cell...

Alzheimer's disease (AD) is a major public health problem. According to the Alzheimer's Association, about 6.2 million people are living with the disease in the USA alone, and that number is projected to rise to nearly 14 million by 2050. Classic treatment eliminates symptoms and does not affect the underlying cause of the...

Globally, lung cancer remains the leading cause of cancer mortality, with about 2 million new diagnoses and 1.8 million deaths annually. Neoplasms of the lungs are the second most common cancer diagnosis among men and women worldwide (after prostate and breast cancer, respectively). This novel approach gained widespread popularity...

In 2020 over 573,000 new bladder cancer (BC) cases and around 212,000 BC deaths were estimated to occur worldwide, representing approximately 3% of all new cancer cases and more than 2% of cancer deaths. BC ranks as the tenth most common cancer diagnosed and the 13th most common cause of cancer mortality worldwide.

In the whole world, the German health care system is recognized as one of the best and most advanced systems. This is because it consistently delivers impressive patient outcomes. Worldometers shows that the average life expectancy in Germany is around 81.7 years. This data allows placing the country among the global leaders in...

In recent years, doctors in developed countries have increasingly used immunotherapy treatment for leukemia. Healthcare professionals in Germany use innovative drugs that help cope with even refractory and relapsing forms of leukemia. Immunotherapy is mainly used for acute lymphocytic leukemia.

Immunotherapy is one of the most effective treatment options for lymphoma. It is used in combination with chemotherapy and has also become a life-saving treatment for many patients whose tumor has recurred and chemotherapy is no longer working. Some types of immunotherapy are so effective that they can even cure aggressive end-stage lymphomas.